10 Angstroms is dedicated to bringing innovative systems and equipment to the nanotechnology R&D market. The company provides both sales representation and service for advanced instrumentation companies.
The CSpace Volumetric Imaging System (static volume display technology) is the company's flagship technology that is being rapidly developed. CSpace uses a clear volumetric image space within which invisible nano-size up-conversion material is dispersed. A volumetric 3D image is rendered when invisible laser beams are precisely directed into the image space, exciting the nano-materials to emit visible light and thus display a full color, volumetric image.
The company is commercializing novel instrumentation and services for rapidly and comprehensively conducting high-throughput nucleotide sequencing, with specific application to the sequencing of whole genomes and ultra-deep sequencing of target genes.
Providing complete solutions for optical and thin film processing needs including miniature optical components and assemblies; design and manufacture custom vacuum systems and assemblies; unique thin-film deposition and etching techniques.
With expertise in advanced materials R&D, technology and software development, and industrial process development, Accelergy is providing research and development capabilities and the process of advanced materials commercialization for the energy markets.
Accium offers laboratory services based on its Accelerator Mass Spectrometry platform used to detect 14C/12C ratios which provided 1,000 times more sensitivity than the most sensitive method available today such as LC/MS. It is now possible to trace biomolecule delivery in healthy subjects with low attomole sensitivity.
Aculon specializes in inventing and commercializing unique molecular-scale surface and interfacial coatings leveraging nanotechnology discoveries made at Princeton University. From electronic device and component manufacturing to industrial metal finishing to consumer appliances and electronics, Aculon adds value through nano-scale surface modification that delivers superior performance, process simplification and favorable economics.
The company has developed a proprietary formulation technology called HDDS that converts drugs that do not dissolve well in water, or hydrophobic drugs, into microparticles or nanoparticles of the drug embedded in small microspheres, such that the drug can more rapidly dissolve in water.